167 related articles for article (PubMed ID: 35326724)
1. A Gene Co-Expression Network-Based Drug Repositioning Approach Identifies Candidates for Treatment of Hepatocellular Carcinoma.
Yuan M; Shong K; Li X; Ashraf S; Shi M; Kim W; Nielsen J; Turkez H; Shoaie S; Uhlen M; Zhang C; Mardinoglu A
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326724
[TBL] [Abstract][Full Text] [Related]
2. Prediction of drug candidates for clear cell renal cell carcinoma using a systems biology-based drug repositioning approach.
Li X; Shong K; Kim W; Yuan M; Yang H; Sato Y; Kume H; Ogawa S; Turkez H; Shoaie S; Boren J; Nielsen J; Uhlen M; Zhang C; Mardinoglu A
EBioMedicine; 2022 Apr; 78():103963. PubMed ID: 35339898
[TBL] [Abstract][Full Text] [Related]
3. Identifying prognostic features by bottom-up approach and correlating to drug repositioning.
Li W; Yu J; Lian B; Sun H; Li J; Zhang M; Li L; Li Y; Liu Q; Xie L
PLoS One; 2015; 10(3):e0118672. PubMed ID: 25738841
[TBL] [Abstract][Full Text] [Related]
4. Repositioning drugs by targeting network modules: a Parkinson's disease case study.
Yue Z; Arora I; Zhang EY; Laufer V; Bridges SL; Chen JY
BMC Bioinformatics; 2017 Dec; 18(Suppl 14):532. PubMed ID: 29297292
[TBL] [Abstract][Full Text] [Related]
5. Dynamic protein interaction modules in human hepatocellular carcinoma progression.
Yu H; Lin CC; Li YY; Zhao Z
BMC Syst Biol; 2013; 7 Suppl 5(Suppl 5):S2. PubMed ID: 24564909
[TBL] [Abstract][Full Text] [Related]
6. Network neighborhood operates as a drug repositioning method for cancer treatment.
Cüvitoğlu A; Isik Z
PeerJ; 2023; 11():e15624. PubMed ID: 37456868
[TBL] [Abstract][Full Text] [Related]
7. Application of comprehensive bioinformatics approaches to reconnoiter crucial genes and pathways underpinning hepatocellular carcinoma: a drug repurposing endeavor.
Nair G; Hema Sree GNS; Saraswathy GR; Marise VLP; Krishna Murthy TP
Med Oncol; 2021 Oct; 38(12):145. PubMed ID: 34687371
[TBL] [Abstract][Full Text] [Related]
8. Predict New Therapeutic Drugs for Hepatocellular Carcinoma Based on Gene Mutation and Expression.
Yu L; Xu F; Gao L
Front Bioeng Biotechnol; 2020; 8():8. PubMed ID: 32047745
[TBL] [Abstract][Full Text] [Related]
9. Drug Repositioning for P-Glycoprotein Mediated Co-Expression Networks in Colorectal Cancer.
Beklen H; Gulfidan G; Arga KY; Mardinoglu A; Turanli B
Front Oncol; 2020; 10():1273. PubMed ID: 32903699
[TBL] [Abstract][Full Text] [Related]
10. An Integrated System Biology Approach Yields Drug Repositioning Candidates for the Treatment of Heart Failure.
Yang G; Ma A; Qin ZS
Front Genet; 2019; 10():916. PubMed ID: 31608126
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics Analysis Identifies Protein Tyrosine Kinase 7 (PTK7) as a Potential Prognostic and Therapeutic Biomarker in Stages I to IV Hepatocellular Carcinoma.
Zou RC; Liang Y; Li LL; Tang JZ; Yang YP; Geng YC; He J; Luo LY; Li WX; Sun ZW; Yuan HL
Med Sci Monit; 2019 Nov; 25():8618-8627. PubMed ID: 31730575
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
[TBL] [Abstract][Full Text] [Related]
13. Drug repositioning in head and neck squamous cell carcinoma: An integrated pathway analysis based on connectivity map and differential gene expression.
Wei GG; Gao L; Tang ZY; Lin P; Liang LB; Zeng JJ; Chen G; Zhang LC
Pathol Res Pract; 2019 Jun; 215(6):152378. PubMed ID: 30871913
[TBL] [Abstract][Full Text] [Related]
14. Drug repositioning by applying 'expression profiles' generated by integrating chemical structure similarity and gene semantic similarity.
Tan F; Yang R; Xu X; Chen X; Wang Y; Ma H; Liu X; Wu X; Chen Y; Liu L; Jia X
Mol Biosyst; 2014 May; 10(5):1126-38. PubMed ID: 24603772
[TBL] [Abstract][Full Text] [Related]
15. [Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].
Yang SY; Ren H; Li CF; Tang H
Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):773-783. PubMed ID: 33053978
[No Abstract] [Full Text] [Related]
16. Prediction of Novel Drugs for Hepatocellular Carcinoma Based on Multi-Source Random Walk.
Yu L; Su R; Wang B; Zhang L; Zou Y; Zhang J; Gao L
IEEE/ACM Trans Comput Biol Bioinform; 2017; 14(4):966-977. PubMed ID: 27076463
[TBL] [Abstract][Full Text] [Related]
17. MD-Miner: a network-based approach for personalized drug repositioning.
Wu H; Miller E; Wijegunawardana D; Regan K; Payne PRO; Li F
BMC Syst Biol; 2017 Oct; 11(Suppl 5):86. PubMed ID: 28984195
[TBL] [Abstract][Full Text] [Related]
18. A Proteotranscriptomic-Based Computational Drug-Repositioning Method for Alzheimer's Disease.
Lee SY; Song MY; Kim D; Park C; Park DK; Kim DG; Yoo JS; Kim YH
Front Pharmacol; 2019; 10():1653. PubMed ID: 32063857
[TBL] [Abstract][Full Text] [Related]
19. An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification.
Lu S; Meng Z; Tan Y; Wu C; Huang Z; Huang J; Fu C; Stalin A; Guo S; Liu X; You L; Li X; Zhang J; Zhou W; Zhang X; Wang M; Wu J
BMC Complement Med Ther; 2022 Mar; 22(1):54. PubMed ID: 35236335
[TBL] [Abstract][Full Text] [Related]
20. Drug repositioning based on network-specific core genes identifies potential drugs for the treatment of autism spectrum disorder in children.
Gao H; Ni Y; Mo X; Li D; Teng S; Huang Q; Huang S; Liu G; Zhang S; Tang Y; Lu L; Liang H
Comput Struct Biotechnol J; 2021; 19():3908-3921. PubMed ID: 34306572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
